BALA CYNWYD, Pa. (AP) — BALA CYNWYD, Pa. (AP) — Larimar Therapeutics, Inc. (LRMR) on Thursday reported a loss of $13 million in its fourth quarter.
On a per-share basis, the Bala Cynwyd, Pennsylvania-based company said it had a loss of 30 cents.
For the year, the company reported a loss of $36.9 million, or 84 cents per share.
Advertisement
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on LRMR at https://www.zacks.com/ap/LRMR